<?xml version="1.0" encoding="utf-8"?>
<!-- generator="FeedCreator 1.8.0-dev (info@mypapit.net)" -->
<rss version="2.0"  xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Sensimed</title>
        <description></description>
        <link>http://www.sensimed.com/</link>
        <lastBuildDate>Sat, 19 May 2012 14:03:34 GMT</lastBuildDate>
        <generator>FeedCreator 1.8.0-dev (info@mypapit.net)</generator>
		<atom:link href="http://www.sensimed.com/index.php?option=com_ninjarsssyndicator&amp;feed_id=1&amp;format=raw" rel="self" type="application/rss+xml" />        <item>
            <title>Sensimed receives the “Local to Global” Award by PwC</title>
            <link>http://www.sensimed.com/en/news/press-release/125-sensimed-receives-the-local-to-global-award-by-pwc.html</link>
            <description><![CDATA[<p><span style="font-size: 10pt; line-height: 115%; font-family: 'Arial','sans-serif';">Sensimed is proud to announce the company received the “Coup-de-coeur” Award delivered by PwC’s Accelerator as one of the most promising innovative business projects. </span><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="font-size: 10pt; line-height: 115%; font-family: 'Arial','sans-serif';"></span></span></p>
<p><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"></span> </p>]]></description>
            <author> dawit_alemu@sensimed.ch (Administrator)</author>
            <pubDate>Wed, 02 May 2012 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-release/125-sensimed-receives-the-local-to-global-award-by-pwc.html</guid>
        </item>
        <item>
            <title>Continuous 24 hours IOP monitoring for glaucoma with a contact lens sensor - time for a paradigm change</title>
            <link>http://www.sensimed.com/en/news/publications/124-continuous-24-hours-iop-monitoring-for-glaucoma-with-a-contact-lens-sensor-time-for-a-paradigm-change.html</link>
            <description><![CDATA[<p><span style="font-size: 10pt; line-height: 115%; font-family: 'Arial','sans-serif';"><strong>PUBLICATION: </strong>Glaucoma is the main cause of irreversible blindness and intraocular pressure (IOP) is its only modifiable risk factor. The importance of robust lowering of IOP for prevention of glaucoma onset and progression is well established. Although IOP is a dynamic parameter with individual circadian rhythms, current management usually relies on single IOP measurements during regular clinic hours performed a few times a year. Mansouri K., Weinreb R. Swiss Med Wkly. 2012 Mar 28;142:0. doi: 10.4414/smw.2012.13545.</span></p>]]></description>
            <author> fanny_severin@sensimed.ch (Fanny Sévérin)</author>
            <pubDate>Thu, 29 Mar 2012 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/publications/124-continuous-24-hours-iop-monitoring-for-glaucoma-with-a-contact-lens-sensor-time-for-a-paradigm-change.html</guid>
        </item>
        <item>
            <title>SENSIMED received product registration in Australia and Canada</title>
            <link>http://www.sensimed.com/en/news/press-release/120-sensimed-received-product-registration-in-australia-and-canada.html</link>
            <description><![CDATA[<p><span style="font-size: 10pt; line-height: 115%; font-family: 'Arial','sans-serif';">Sensimed announced today the registration and commercialization in Australia and Canada of the SENSIMED Triggerfish<sup>®</sup>.</span><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="color: #000000;" color="#000000"> </span></span><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="color: #000000;" color="#000000"></span></span></p>
<p><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"></span> </p>]]></description>
            <author> dawit_alemu@sensimed.ch (Administrator)</author>
            <pubDate>Thu, 16 Feb 2012 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-release/120-sensimed-received-product-registration-in-australia-and-canada.html</guid>
        </item>
        <item>
            <title>Los avances de la Tecnología Oftalmológica llegan a las lentes</title>
            <link>http://www.sensimed.com/en/news/press-articles/121-los-avances-de-la-tecnologia-oftalmologica-llegan-a-las-lentes.html</link>
            <description><![CDATA[<p><span lang="IT">LA VOZ DE ALMERÍA</span><span style="font-size: 1.2em;"> - La unidad de Oftalmologíca del Hospital Virgen del Mar ya implanta el sistema Sensimed Triggerfish, capaz de monitorizar la presión ocular<br /></span></p>
<div style="overflow: hidden; color: #000000; background-color: #ffffff; text-align: left; text-decoration: none;"><span style="color: #003399;"><br /></span></div>]]></description>
            <author> fanny_severin@sensimed.ch (Fanny Sévérin)</author>
            <pubDate>Thu, 09 Feb 2012 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-articles/121-los-avances-de-la-tecnologia-oftalmologica-llegan-a-las-lentes.html</guid>
        </item>
        <item>
            <title>SENSIMED to open distribution channels in Europe</title>
            <link>http://www.sensimed.com/en/news/press-release/118-sensimed-and-nidek-to-cooperate-in-japan.html</link>
            <description><![CDATA[<p></p>
<p><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="color: #000000;" color="#000000">Sensimed announced today the company has signed cooperation agreements in Spain, Portugal, UK and Ireland to strengthen its sales, service and support network in Europe. </span></span><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="color: #000000;" color="#000000"></span></span></p>
<p><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"></span> </p>]]></description>
            <author> dawit_alemu@sensimed.ch (Administrator)</author>
            <pubDate>Tue, 31 Jan 2012 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-release/118-sensimed-and-nidek-to-cooperate-in-japan.html</guid>
        </item>
        <item>
            <title>Glaucoma Review 2011</title>
            <link>http://www.sensimed.com/en/news/press-articles/117-the-straits-times-smart-lens-for-clearer-glaucoma-test.html</link>
            <description><![CDATA[<p>OPHTHALMOLOGY TIMES EUROPE - "The biggest opportunity of the year is the  opening up of 24 hour methods of evaluation of IOP"....</p>]]></description>
            <author> fanny_severin@sensimed.ch (Fanny Sévérin)</author>
            <pubDate>Tue, 03 Jan 2012 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-articles/117-the-straits-times-smart-lens-for-clearer-glaucoma-test.html</guid>
        </item>
        <item>
            <title>Le novita' dell'anno su diagnosi e terapia del glaucoma</title>
            <link>http://www.sensimed.com/en/news/press-articles/115-le-novita-dellanno-su-diagnosi-e-terapia-del-glaucoma.html</link>
            <description><![CDATA[<p><span lang="IT">CORRIERE DELLA SERA (edizione pugliese)</span><span style="font-size: 1.2em;"> - Una malattia aggressiva, nonostante la terapia medica e quella chirurgica abbiano fatto passi importanti<br /></span></p>
<div style="overflow: hidden; color: #000000; background-color: #ffffff; text-align: left; text-decoration: none;"><span style="color: #003399;"><br /></span></div>]]></description>
            <author> fanny_severin@sensimed.ch (Fanny Sévérin)</author>
            <pubDate>Sun, 13 Nov 2011 14:09:49 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-articles/115-le-novita-dellanno-su-diagnosi-e-terapia-del-glaucoma.html</guid>
        </item>
        <item>
            <title>The contact lens with a microchip to spot glaucoma</title>
            <link>http://www.sensimed.com/en/news/press-articles/114-the-contact-lens-with-a-microship-to-spot-glaucoma.html</link>
            <description><![CDATA[<p><span style="font-size: 1.2em;">THE MAIL ON SUNDAY - An electronic contact lens with a microchip in it is being used for the first time in the fight against a leading cause of blindness. The condition, glaucoma, is thought to affect half a million Britons – yet studies show that half of all cases remain undiagnosed.</span></p>
<div style="overflow: hidden; color: #000000; background-color: #ffffff; text-align: left; text-decoration: none;"><br />Read more: <span style="color: #003399;">http://www.dailymail.co.uk/health/article-2058038/The-contact-lens-microchip-spot-glaucoma.html#ixzz1eKh3bRI1</span></div>]]></description>
            <author> fanny_severin@sensimed.ch (Fanny Sévérin)</author>
            <pubDate>Sun, 06 Nov 2011 14:09:49 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-articles/114-the-contact-lens-with-a-microship-to-spot-glaucoma.html</guid>
        </item>
        <item>
            <title>Patient recruitment completed for the first USA clinical study</title>
            <link>http://www.sensimed.com/en/news/press-release/112-sensimed-and-nidek-to-cooperate-in-japan.html</link>
            <description><![CDATA[<p></p>
<p><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="color: #000000;" color="#000000">SENSIMED announced today the completion of the first clinical study investigation in the USA. SENSIMED Triggerfish is considered to be a non-significant risk (NSR) device for the conduct of clinical investigation in the USA following recent consultation with FDA.</span></span></p>
<p><span style="line-height: 115%; font-family: 'Arial','sans-serif'; font-size: 10pt; mso-fareast-font-family: 'Malgun Gothic'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"></span> </p>
<p></p>
<p></p>
<p></p>]]></description>
            <author> dawit_alemu@sensimed.ch (Administrator)</author>
            <pubDate>Wed, 02 Nov 2011 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-release/112-sensimed-and-nidek-to-cooperate-in-japan.html</guid>
        </item>
        <item>
            <title>Las últimas técnicas han cambiado el tratamiento del glaucoma</title>
            <link>http://www.sensimed.com/en/news/press-articles/123-las-ultimas-tecnicas-han-cambiado-el-tratamiento-del-glaucoma.html</link>
            <description><![CDATA[<p><span lang="IT">REVISTA ADN</span><span style="font-size: 1.2em;"> - Unas lentes de contacto permiten controlar la presión del ojo y facilitan la curación de la enfermedad.<br /></span></p>
<div style="overflow: hidden; color: #000000; background-color: #ffffff; text-align: left; text-decoration: none;"><span style="color: #003399;"><br /></span></div>]]></description>
            <author> fanny_severin@sensimed.ch (Fanny Sévérin)</author>
            <pubDate>Wed, 02 Nov 2011 00:00:00 GMT</pubDate>
            <guid isPermaLink="false">http://www.sensimed.com/en/news/press-articles/123-las-ultimas-tecnicas-han-cambiado-el-tratamiento-del-glaucoma.html</guid>
        </item>
    </channel>
</rss>

